ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Internal Medicine

Top Internal Medicine Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GLENN FORT MD

Internal Medicine

496

$281K

115
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$566
Average prescription price

Avg: $51

BRIAN MONTAGUE DO

Internal Medicine

1,004

$567K

55
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 22%

$565
Average prescription price

Avg: $51

SUSAN CU-UVIN MD

Internal Medicine

772

$390K

43
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 22%

$506
Average prescription price

Avg: $51

KAREN GRANDE MD

Internal Medicine

627

$102K

141
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

23%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 22%

$163
Average prescription price

Avg: $51

NANCY BOTELHO NP

Internal Medicine

626

$99K

115
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 22%

$158
Average prescription price

Avg: $51

AMY GOLDFARB MD

Internal Medicine

6,844

$1.04M

236
163 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$151
Average prescription price

Avg: $51

FADI AL-BILBEISI M.D.

Internal Medicine

1,227

$177K

143
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

77%
prescriptions for brand name drugs

Avg: 22%

$144
Average prescription price

Avg: $51

RINCHEN-TZO EMGUSHOV MD

Internal Medicine

5,684

$787K

228
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 22%

$138
Average prescription price

Avg: $51

SAPNA CHOWDHRY MD

Internal Medicine

5,656

$770K

194
57 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$136
Average prescription price

Avg: $51

LISA HARRINGTON MD

Internal Medicine

749

$87.4K

86
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$117
Average prescription price

Avg: $51

LUISA MILLER M.D.

Internal Medicine

753

$87.7K

20
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$117
Average prescription price

Avg: $51

JOHN ADAMS

Internal Medicine

694

$63.3K

110
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$91
Average prescription price

Avg: $51

DANIEL HOCHBERGER M.D.

Internal Medicine

6,111

$550K

274
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 22%

$90
Average prescription price

Avg: $51

LISA NOYES-DUGUAY M.D.

Internal Medicine

845

$75.3K

80
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$89
Average prescription price

Avg: $51

PURVI CHOKSHI MD

Internal Medicine

3,224

$283K

55
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$88
Average prescription price

Avg: $51

FADI MANSOURATI MD

Internal Medicine

7,877

$654K

267
210 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$83
Average prescription price

Avg: $51

ERIC NEWTON MD

Internal Medicine

1,028

$85K

177
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 22%

$83
Average prescription price

Avg: $51

CHRISTY DIBBLE MD

Internal Medicine

573

$47.1K

160
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 22%

$82
Average prescription price

Avg: $51

MICHAEL NISSENSOHN M.D.

Internal Medicine

914

$72.9K

165
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$80
Average prescription price

Avg: $51

JOHN MISKOVSKY MD

Internal Medicine

7,513

$595K

318
240 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$79
Average prescription price

Avg: $51

CLAUDE YOUNES M.D.

Internal Medicine

7,974

$599K

387
308 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $51

WILLIAM PALUMBO MD

Internal Medicine

1,531

$114K

107
75 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$74
Average prescription price

Avg: $51

JONATHAN LEVISS MD

Internal Medicine

752

$55.7K

69
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$74
Average prescription price

Avg: $51

SOUFIAN ALMAHAMEED M.D.

Internal Medicine

554

$40.6K

95
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $51

JEFFREY DROGIN MD

Internal Medicine

13,818

$1M

651
614 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$72
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank